What does a successful retirement look like? If it means financial security through steady income sources, then you can get ...
Which of the highest-yielding healthcare stocks are value traps or golden opportunities?
Pfizer is almost certain to survive the current headwinds as a business. However, the dividend may not. It will be important ...
Pfizer Inc. Buy: market overreacts to Q4 loss and 2026 guidance; oncology-led growth, 102-candidate pipeline, and dividend offer upside. Click for this PFE update.
Eli Lilly and Novo Nordisk may want to enjoy their duopoly while they can.
Passive income can help secure your retirement, but building a dependable income is not easy. You must be able to identify ...
Explore February’s top Large Cap Value (GASV) dividend “dogs” with analyst targets, ideal yields and buy signals—see ...
The company expects to launch more than 20 pivotal late-stage trials this year.
Pfizer Inc. (NYSE:PFE) Q4 2025 Earnings Call Transcript February 3, 2026 Pfizer Inc. beats earnings expectations. Reported ...
As we navigate through the unpredictable market conditions, below is a list of the bottom 10 large cap stocks with the lowest dividend growth grades. The stocks span various sectors, including ...
Free Malaysia Today on MSN
Pfizer reports quarterly loss, affirms 2026 targets
The pharma firm reported a US$1.65 billion loss in Q4 2025, driven by a major write-down and falling Covid-19 product sales.
Pfizer reported a quarterly loss Tuesday following a large write-down, denting shares as it confirmed 2026 financial targets with lower revenues.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results